OR WAIT null SECS
August 02, 2022
FDA’s hybrid inspection model will remain a regular means for supplementing onsite inspections and will be further integrated into the agency’s oversight operations.
GSK has completed its demerger of Haleon and has signed an agreement to help support future pandemic preparedness in Europe.
August 01, 2022
DuPont’s new manufacturing site will expand its biopharmaceutical tubing manufacturing capabilities.
The United States has agreed to purchase 66 million doses of Moderna’s bivalent COVID-19 booster candidate for $1.74 billion.
The European Commission has approved Rinvoq (upadacitinib) for treatment of active non-radiographic axial spondyloarthritis.
The European Commission has granted marketing authorization to Upstaza (eladocagene exuparvovec) for treatment of aromatic L-amino acid decarboxylase (AADC) deficiency.
July 27, 2022
Shimadzu’s new ultra-high performance liquid chromatography system is designed to solve common problems in biopharma analysis.
Roche’s new test is the first available immunoassay that allows for simultaneous, independent determination of the hepatitis C virus antigen and antibody status.
WuXi STA is opening a new large-scale oligonucleotide and peptide manufacturing facility.
July 26, 2022
Scrutiny of accelerated approvals has generated a range of reform proposals to accelerate the conduct of confirmatory studies.